Concomitant Medication Use With Xiyanping Injection and the Risk of Suspected Allergic Reactions: A Nested Case-Control Study Based on China's National Medical Insurance Database
Introduction: Xiyanping injection (XYP), a type of Traditional Chinese Medicine, is widely used and often applied in combination with other medications in treating bronchitis, tonsillitis, and bacillary dysentery in China. In recent years, an elevated risk of allergic reactions has been observed fol...
Saved in:
Main Authors: | Xunliang Tong (Author), Xiaochen Zhu (Author), Chunping Wang (Author), Yifan Zhou (Author), Yingying Yan (Author), Siyan Zhan (Author), He Zhu (Author), Sheng Han (Author), Yinchu Cheng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
by: Yumei He, et al.
Published: (2023) -
Adebrelimab plus chemotherapy vs. chemotherapy for treatment of extensive-stage small-cell lung cancer from the US and Chinese healthcare sector perspectives: a cost-effectiveness analysis to inform drug pricing
by: Yena Gan, et al.
Published: (2023) -
Xiyanping injection combined with acitretin for psoriasis vulgaris: A systematic review and meta-analysis
by: Man-Ning Wu, et al.
Published: (2022) -
Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy
by: Linhu Ye, et al.
Published: (2021) -
Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis
by: Guoxu Wei, et al.
Published: (2021)